Skip to main content

Advertisement

Log in

Decline of IgG pertussis toxin measured in umbilical cord blood, and neonatal and early infant serum

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Maternal pertussis-specific antibodies are passively acquired by infants during pregnancy. An IgG pertussis toxin (IgG-PT) concentration of >20 U/ml is considered to protect neonates against pertussis. To evaluate the IgG concentration at birth and during the first two months of life, we examined the IgG-PT concentration in the umbilical cord blood and three times during the neonatal and early infant period. IgG-PT was measured by validated IgG-specific enzyme-linked immunosorbent assays (ELISA) in umbilical cord blood and in Guthrie card blood samples of umbilical cord blood in 2,790 children, born between 1 August 2006 and 1 December 2008. These measurements were comparable. All children with concentrations of IgG-PT >30 U/ml were included. IgG-PT was also measured in Guthrie card blood samples, when the neonates or early infants were 5 days, 1 month and 2 months old. The mean concentrations of IgG-PT were calculated. The mean concentration of IgG-PT in umbilical cord blood was 60.1 U/ml (LN 4.1; 0.6 SD; n = 103). At the age of 5 days, 1 month and 2 months, the mean concentration of IgG-PT was 40.6 U/ml (LN 3.7; 0.5 SD; n = 103), 20.7 U/ml (LN 3.0; 0.7 SD; n = 62) and 16.7 U/ml (LN 2.8; 0.9 SD; n = 61), respectively. Four percent of the neonates had a concentration of IgG-PT >30 U/ml in umbilical cord blood, which declined to levels around the concentration needed for protection against pertussis (>20 U/ml) in the first two months of life. Hence, it is of great importance to further investigate the safety of maternal immunisation during pregnancy to prevent life-threatening pertussis in newborns.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Mooi FR, de Greeff SC (2007) The case for maternal vaccination against pertussis. Lancet Infect Dis 7:614–624

    Article  PubMed  Google Scholar 

  2. Versteegh FGA (2005) Pertussis: a concise review including a brief history and new insights in diagnosis, incidence and clinical manifestations. Rev Med Microbiol 3

  3. de Greeff SC, de Melker HE, van Gageldonk PGM, Schellekens JFP, van der Klis FRM, Mollema L, Mooi FR, Berbers GA (2010) Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS One 5(12):e14183. doi:10.1371/journal.pone.0014183

    Article  PubMed Central  PubMed  Google Scholar 

  4. Gonik B, Puder KS, Gonik N, Kruger M (2005) Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants. Infect Dis Obstet Gynecol 13(2):59–61

    Article  PubMed Central  PubMed  Google Scholar 

  5. de Melker HE, Versteegh FGA, Schellekens JFP, Teunis PFM, Kretzschmar M (2006) The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect 53:106–113

    Article  PubMed  Google Scholar 

  6. Wang CQ, Zhu QR (2011) Seroprevalence of Bordetella pertussis antibody in children and adolescents in China. Pediatr Infect Dis J 30(7):593–596

    Article  PubMed  Google Scholar 

  7. Kretzschmar M, Teunis PF, Pebody RG (2010) Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Med 7(6):e1000291

    Article  PubMed Central  PubMed  Google Scholar 

  8. Wood N, McIntyre P, Marshall H, Roberton D (2010) Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatr Infect Dis J 29(3):209–215

    Article  PubMed  Google Scholar 

  9. van den Berg JP, Westerbeek EAM, van der Klis FRM, Berbers GAM, van Elburg RM (2011) Transplacental transport of IgG antibodies to preterm infants: a review of the literature. Early Hum Dev 87:67–72

    Article  PubMed  Google Scholar 

  10. Healy CM, Munoz FM, Rench MA, Halasa NB, Edwards KM, Baker CJ (2004) Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis 190:335–340

    Article  PubMed  Google Scholar 

  11. Healy CM, Baker CJ (2006) Prospects for prevention of childhood infections by maternal immunization. Curr Opin Infect Dis 19:271–276

    Article  PubMed  Google Scholar 

  12. Edwards KM (2003) Pertussis: an important target for maternal immunization. Vaccine 21:3483–3486

    Article  CAS  PubMed  Google Scholar 

  13. Van Rie A, Wendelboe AM, Englund JA (2005) Role of maternal pertussis antibodies in infants. Pediatr Infect Dis J 24(5 Suppl):S62–S65

    PubMed  Google Scholar 

  14. Elahi S, Buchanan RM, Babiuk LA, Gerdts V (2006) Maternal immunity provides protection against pertussis in newborn piglets. Infect Immun 74(5):2619–2627

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Gall SA, Myers J, Pichichero M (2011) Maternal immunization with tetanus–diphtheria–pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 204(4):334.e1–334.e5

    Article  Google Scholar 

  16. Nooitgedagt JE, de Greeff SC, Elvers BH, de Melker HE, Notermans DW, van Huisseling H, Versteegh FGA (2009) Seroprevalence of Bordetella pertussis infection during pregnancy measured by IgG antibodies against pertussis toxin. Clin Infect Dis 49:1086–1089

    Article  PubMed  Google Scholar 

  17. Cherry JD, Gornbein J, Heininger U, Stehr K (1998) A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16:1901–1906

    Article  CAS  PubMed  Google Scholar 

  18. Cherry JD (2007) Immunity to pertussis. Clin Infect Dis 44:1278–1279

    Article  PubMed  Google Scholar 

  19. Storsaeter J, Hallander HO, Gustafsson L, Olin P (2003) Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis. Vaccine 21:3542–3549

    Article  PubMed  Google Scholar 

  20. de Melker HE, Versteegh FGA, Conyn-Van Spaendonck MA, Elvers LH, Berbers GA, van Der Zee A, Schellekens JF (2000) Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 38(2):800–806

    PubMed Central  PubMed  Google Scholar 

  21. Centers for Disease Control and Prevention (CDC) (2013) Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women—Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 62:131–135

    Google Scholar 

  22. Healy CM, Rench MA, Baker CJ (2013) Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis 56(4):539–544

    Article  CAS  PubMed  Google Scholar 

  23. van Ommen CC, Elvers LH, Notermans DW, van Huisseling JC, Teunis PF, Versteegh FGA (2012) Antibody levels against B. pertussis in neonates measured in dried blood spots. Vaccine 30(16):2697–2700

    Article  PubMed  Google Scholar 

  24. Wolfram Research, Inc. (2010) Mathematica, Version 8.0. Champaign, IL

  25. Heininger U, Riffelmann M, Leineweber B, Wirsing von Koenig CH (2009) Maternally derived antibodies against Bordetella pertussis antigens pertussis toxin and filamentous hemagglutinin in preterm and full term newborns. Pediatr Infect Dis J 28:443–445

    Article  PubMed  Google Scholar 

  26. de Voer RM, van der Klis FRM, Nooitgedagt JE, Versteegh FGA, van Huisseling JCM, van Rooijen DM, Sanders EA, Berbers GA (2009) Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis. Clin Infect Dis 49:58–64

    Article  PubMed  Google Scholar 

  27. van den Berg JP, Westerbeek EA, Berbers GA, van Gageldonk PG, van der Klis FR, van Elburg RM (2010) Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in preterm compared with term infants. Pediatr Infect Dis J 29:801–805

    Article  PubMed  Google Scholar 

  28. RIVM. LCI-richtlijn pertussis. Publication date: 04-05-2011. Modification date: 05-07-2013

  29. Ercan TE, Sonmez C, Vural M, Erginoz E, Torunoğlu MA, Perk Y (2013) Seroprevalance of pertussis antibodies in maternal and cord blood of preterm and term infants. Vaccine 31(38):4172–4176

    Article  CAS  PubMed  Google Scholar 

  30. Englund JA (2007) The influence of maternal immunization on infant immune responses. J Comp Pathol 137(Suppl 1):S16–S19

    Article  CAS  PubMed  Google Scholar 

  31. Healy CM (2012) Vaccines in pregnant women and research initiatives. Clin Obstet Gynecol 55:474–486

    Article  PubMed  Google Scholar 

  32. Malek A, Sager R, Schneider H (1994) Maternal-fetal transport of immunoglobulin G and its subclasses during the third trimester of human pregnancy. Am J Reprod Immunol 32:8–14

    Article  CAS  PubMed  Google Scholar 

  33. Plotkin SA (2008) Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis 47(3):401–409

    Article  PubMed  Google Scholar 

  34. Gabutti G, Bergamini M, Bonanni P, Guido M, Fenoglio D, Giammanco A, Sindoni L, Zotti C, Boddi V, Bamfi F, Severini R, Bechini A, Boccalini S, Crovari P; Collaborative Group for the Study of Pertussis (2008) Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy. Epidemiol Infect 136:1576–1584

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Storsaeter J, Hallander HO, Gustafsson L, Olin P (1998) Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16:1907–1916

    Article  CAS  PubMed  Google Scholar 

  36. Olin P, Hallander HO, Gustafsson L, Reizenstein E, Storsaeter J (2001) How to make sense of pertussis immunogenicity data. Clin Infect Dis 33:S288–S291

    Article  CAS  PubMed  Google Scholar 

  37. Deville JG, Cherry JD, Christenson PD, Pineda E, Leach CT, Kuhls TL, Viker S (1995) Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis 21(3):639–642

    Article  CAS  PubMed  Google Scholar 

  38. Leuridan E, Hens N, Peeters N, de Witte L, van der Meeren O, van Damme P (2011) Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatr Infect Dis J 30(7):608–610

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. C. S. Smallenburg.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smallenburg, L.C.S., van Welie, N.A., Elvers, L.H. et al. Decline of IgG pertussis toxin measured in umbilical cord blood, and neonatal and early infant serum. Eur J Clin Microbiol Infect Dis 33, 1541–1545 (2014). https://doi.org/10.1007/s10096-014-2110-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-014-2110-2

Keywords

Navigation